European Journal of Clinical Pharmacology
短名 | Eur. J. Clin. Pharmacol. |
Journal Impact | 2.60 |
国际分区 | PHARMACOLOGY & PHARMACY(Q3) |
期刊索引 | SCI Q3中科院 3 区 |
ISSN | 0031-6970, 1432-1041 |
h-index | 123 |
国内分区 | 医学(3区)医学药学(3区) |
《欧洲临床药理学杂志》发表了关于人类临床药理学和药物治疗各个方面的原创论文。欢迎提交以下主题的稿件:治疗试验、药代动力学/药效学、药物遗传学、药物代谢、药物不良反应、药物相互作用、药物开发的各个方面、与临床药理学教学有关的发展、药物流行病学以及与合理处方有关的事项和安全用药。与这些主题相关的方法论贡献也受到欢迎。来自动物实验的数据仅在同一篇论文中报告的人类原始数据的背景下被接受。如果这些信息与功能数据或新的有趣变体相关联,EJCP 只会考虑描述不同人群中等位基因变体频率的手稿。高度相关的频率差异对各自人群的药物治疗有重大影响,可以作为致编辑的信提交。作为新药开发的一部分的简单的 I 期药代动力学或药效学研究只有在论文涉及时才会考虑发表 -一种在某种基本或基本方式上有趣且新颖的化合物,或-在某种基本意义上是原创的方法,或-一种非常出乎意料的结果,或-在某种基本或基本意义上在科学上新颖的结论。
期刊主页投稿网址涉及主题 | 医学生物内科学药理学化学内分泌学生物化学心理学遗传学生物信息学病理精神科药代动力学麻醉有机化学外科物理 |
出版信息 | 出版商: Springer Science and Business Media Deutschland GmbH,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1968,原创研究文献占比: 74.07%,自引率:4.20%, Gold OA占比: 32.62% |
平均审稿周期 | 网友分享经验:一般,3-8周 |
平均录用比例 | 网友分享经验:容易 |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Dose reduction and discontinuation due to the combination of CDK4/6 inhibitors and endocrine drugs: a systematic review and meta-analysis
2024-9-13
Preventive effects of first-generation antihistamine on emergence agitation or delirium: a systematic review
2024-9-12
Efficacy and safety of ticagrelor monotherapy following a brief DAPT vs. prolonged 12-month DAPT in ACS patients post-PCI: a meta-analysis of RCTs
2024-9-12
Efficacy of tacrolimus versus cyclosporine after lung transplantation: an updated systematic review, meta-analysis, and trial sequential analysis of randomized controlled trials
2024-9-11
Beta-blockers and breastfeeding: a real-life prospective study
2024-9-11
The cost-effectiveness analysis of semaglutide for the treatment of adult and adolescent patients with overweight and obesity: a systematic review
2024-9-10
ChatGPT does make up scientific references: should it be currently renamed CheatGPT?
2024-9-10
Approaches for posaconazole therapeutic drug monitoring and their clinical benefits
2024-9-9
Voriconazole therapeutic drug monitoring including analysis of CYP2C19 phenotype in immunocompromised pediatric patients with invasive fungal infections
2024-9-6
Therapeutic drug monitoring in tuberculosis
2024-9-6
Fixed parameters in the population pharmacokinetic modeling of valproic acid might not be suitable: external validation in Chinese adults with epilepsy or after neurosurgery
2024-8-29
Reference guides for the safe use of drugs during pregnancy: a systematic review and comparative analysis
2024-8-26
Evaluation of pharmacokinetic target attainment and hematological toxicity of linezolid in pediatric patients
2024-8-25
Correction to: Use of antibiotics in the early COVID‑19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic
2024-8-22
Prognostic effect of a vasopressin V2 receptor antagonist in acute congestive heart failure patients with hypoperfusion, the wet–cold pattern
2024-8-21
Evaluation of SLC6A2 and CYP2D6 polymorphisms’ effects on atomoxetine treatment in attention deficit and hyperactivity disorder
2024-8-19
Serious gaming as potential training tool for recognition of adverse drug reactions: side-effect exposure—medical education (SeeMe)
2024-8-19
Model-informed dose optimization of mycophenolic acid in pediatric kidney transplant patients
2024-8-17
Therapeutic drug monitoring for valproate: deriving a novel formula for calculation of free concentration
2024-8-16
Short-term usage of proton pump inhibitors during admission was associated with increased risk of rehospitalization in critically ill patients with myocardial infarction: a cohort study
2024-8-14
Characteristics of isoniazid-induced psychosis: a systematic review of case reports and case series
2024-8-13
Reliability and validity of the Turkish version of the medication practical barriers to adherence questionnaire in patients with chronic diseases
2024-8-7
Efficacy and safety of ramucirumab for gastric or gastro-esophageal junction adenocarcinoma: a systematic review and meta-analysis
2024-8-5
Drug administration via feeding tubes—a procedure that carries risks: systematic identification of critical factors based on commonly administered drugs in a cohort of stroke patients
2024-7-29
Neuronal toxicity of monoclonal antibodies (mAbs): an analysis of post-marketing reports from FDA Adverse Event Reporting System (FAERS) safety database
2024-7-25
Correction to: Immune‑related serious adverse events with immune checkpoint inhibitors: systematic review and network meta‑analysis
2024-7-24
Author’s reply to the letter to the editor: “Effects of dapagliflozin and empagliflozin on 6‑min walk distance in heart failure with preserved and reduced ejection fraction: A systematic review and meta‑analysis of randomized controlled trials involving 2624 patients”
2024-7-23
Letter to the editor: "Effects of dapagliflozin and empagliflozin on 6-min walk distance in heart failure with preserved and reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials involving 2624 patients"
2024-7-21
No evidence of clinical efficacy of oxomemazine in cough, according to a systematic review
2024-7-17
Use of antibiotics in the early COVID-19 pandemic in Poland, the Netherlands and Spain, from erraticism to (more) logic
2024-7-17
Statin treatment for primary and secondary prevention in elderly patients—a cross-sectional study in Stockholm, Sweden
2024-7-16
Effects of active vitamin D analogs and calcimimetic agents on PTH and bone mineral biomarkers in hemodialysis patients with SHPT: a network meta-analysis
2024-7-13
Consumers’ knowledge and experiences of adverse drug reaction reporting in Australia: a national survey
2024-7-12
Efficacy of cannabis-based medicine in the treatment of Tourette syndrome: a systematic review and meta-analysis
2024-7-10
Efficacy and safety of different pharmacological interventions in the treatment of tardive dyskinesia: a systematic review and network meta-analysis
2024-7-6
Time-course and dose-effect of omalizumab in treating chronic idiopathic urticaria/chronic spontaneous urticaria
2024-7-5
Impact of CYP2D6*2, CYP2D6*35, rs5758550, and related haplotypes on risperidone clearance in vivo
2024-7-4
Real-world safety and effectiveness of pirfenidone and nintedanib in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
2024-7-4
Effect of subcutaneous vs. intravenous tocilizumab in patients with severe COVID-19: a systematic review
2024-6-27
Risk of renal impairment in atypical antipsychotics: a systematic review and meta-analysis
2024-6-25
Use of drugs for hypertension or heart failure and the risk of death in COVID-19: association with loop-diuretics
2024-6-24
Risk of agranulocytosis with metamizole in comparison with alternative medications based on health records in Spain
2024-6-22
Is atezolizumab plus bevacizumab as first-line therapy for unresectable hepatocellular carcinoma superior to lenvatinib? a systematic review and meta‑analysis
2024-6-22
Effect of low-molecular-weight heparin calcium combined with magnesium sulfate and labetalol on coagulation, vascular endothelial function and pregnancy outcome in early-onset severe preeclampsia
2024-6-21
Population pharmacokinetics of free and liposome-encapsulated mitoxantrone in patients with relapsed/refractory lymphoma or small cell lung cancer
2024-6-21
Development and validation of individualized tacrolimus dosing software for Chinese pediatric liver transplantation patients: a population pharmacokinetic approach
2024-6-21
Quantitative evaluation of the efficacy and safety profiles of two types of targeted inhibitors combined with endocrine therapy in ER+/HER2− metastatic breast cancer
2024-6-20
Treatment-related adverse events in patients with advanced breast cancer receiving adjuvant AKT inhibitors: a meta-analysis of randomized controlled trials
2024-6-18
Assessment of a systematic approach for implementing novel medications in clinical practice: an observational study with dapagliflozin
2024-6-10
How can polymyxin B be dosed based on current pharmacokinetic knowledge?
2024-6-7
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远